The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects.
- DOI
- 10.1530/eje-15-0451
- Published
- 2015-08-11
- Container
- Eur J Endocrinol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1530/eje-15-0451,
title = {The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects.},
author = {Donze SH and Meijer CR and Kant SG and Zandwijken GR and van der Hout AH and van Spaendonk RM and van den Ouweland AM and Wit JM and Losekoot M and Oostdijk W.},
year = {2015},
journal = {Eur J Endocrinol},
doi = {10.1530/eje-15-0451},
url = {https://doi.org/10.1530/eje-15-0451}
}RIS
TY - JOUR TI - The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects. AU - Donze SH AU - Meijer CR AU - Kant SG AU - Zandwijken GR AU - van der Hout AH AU - van Spaendonk RM AU - van den Ouweland AM AU - Wit JM AU - Losekoot M AU - Oostdijk W. PY - 2015 JO - Eur J Endocrinol DO - 10.1530/eje-15-0451 UR - https://doi.org/10.1530/eje-15-0451 ER -
APA
SH, D., CR, M., SG, K., GR, Z., AH, V. D. H., RM, V. S., AM, V. D. O., JM, W., M, L., & W., O. (2015). The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects.. Eur J Endocrinol. https://doi.org/10.1530/eje-15-0451
Source records
- europe-pmc · retrieved 2026-09-26T04:58:01.271Z